The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
Project Overview
China has the 3rd highest Tuberculosis (TB) burden in the world and is categorized as both high burden for TB and multidrug-resistant TB (MDR-TB) by WHO. In 2022, China had approximately 748,000 incident TB cases (52 cases per 100,000 population), accounting for 7.1% of the global burden. China had a case detection rate of 67% with 501,261 new and relapse TB cases notified. Among them, 58% TB cases in China are bacteriological positive and about 25% cases are asymptomatic.
Overall, compared to some high burden TB countries, China has relatively lower TB incidence and a high functioning TB control network. However, to meet the UN Sustainable Development Goals (SDG) and End TB targets, it is crucial to detect TB cases earlier in the disease progression, which can be achieved through cost-effective active case finding and more sensitive diagnostic testing.
Focusing on active cast finding approaches in China, starting in 2025, CHAI will partner with China CDC for a 3-year project to provide technical support and ensure its dual objectives of 1) informing policy and procurement decisions in China, and 2) independently assessing and piloting with domestic innovative products to strengthen global evidence for high-quality Chinese diagnostic tools.
Position Overview
The Program Manager will lead and manage the aforementioned China TB project with China CDC, and contribute towards other CHAI TB related initiatives in China. Given the scope and design of this project, within CHAI, the Program Manager will work closely with CHAI’s China Country Team, Global TB Team, and the Analytics and Implementation Research Team. The Program Manager will lead a small team to conduct analytical research, develop program strategies, and support implementation. In addition, the Program Manager is responsible to lead coordination with Chinese government entities, the project's donor the Bill & Melinda Gates Foundation (BMGF), and private sector actors, if deemed relevant.
The Program Manager’s scope of work will consist of the below components:
1. Internal CHAI management (15%)
2. Assist in overall project management (30%)
3. On-site support during implementation (15%)
4. Provide expert technical assistance on TB diagnosis (25%)
5. Perform other relevant duties and technical inputs to the project’s donor BMGF and other partners (15%)
CHAI projects require cross-border cooperation and global coordination with both public and private sector stakeholders. The Program Manager may work independently and/or with mixed teams consisting of project and local site staff from both within CHAI and external partners such as government entities, international organization, private companies and academic institutions. This requires both strategic thinking and execution effectiveness. S/he will be able to work in a flexible, entrepreneurial and results-driven manner under pressure, but still with optimism even in the face of complex challenges.
#jobreference3 #region2
Software Powered by iCIMS
www.icims.com